In a unanimous decision on Thursday, the Supreme Court preserved broad access to the abortion drug mifepristone — at least for now. The justices dismissed the case on a technicality, ruling that the anti-abortion groups and doctors who brought it didn't have a legal right to sue. But the court's decision isn't a solid win for abortion access. The justices didn't weigh in on the substance of the case, meaning it could end up back in front of the court. Already, three Republican-led states are trying to make that happen. Julia Kaye, senior staff attorney with the American Civil Liberties Union's Reproductive Freedom Project, explains the ruling and what's next.

And in headlines: President Joe Biden and other G7 leaders agreed to finance a $50 billion loan to Ukraine to help pay for its war against Russia and rebuild the country's infrastructure, former president Donald Trump schmoozed with House and Senate Republicans during his first visit to Capitol Hill since the Jan. 6 insurrection, and the ACLU and immigrant rights groups sued the Biden administration over the president's executive order severely limiting asylum claims at the southern border.

Show Notes: